First Time Loading...
K

Knotus Co Ltd
KOSDAQ:278650

Watchlist Manager
Knotus Co Ltd
KOSDAQ:278650
Watchlist
Price: 3 295 KRW 0.15%
Updated: May 16, 2024

Intrinsic Value

KNOTUS Co. Ltd. engages in the provision of clinical research services. [ Read More ]

The intrinsic value of one Knotus Co Ltd stock under the Base Case scenario is 2 067.63 KRW. Compared to the current market price of 3 295 KRW, Knotus Co Ltd is Overvalued by 37%.

Key Points:
Intrinsic Value
Base Case
2 067.63 KRW
Overvaluation 37%
Intrinsic Value
Price
K
Worst Case
Base Case
Best Case

Valuation Backtest
Knotus Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Knotus Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Knotus Co Ltd

Provide an overview of the primary business activities
of Knotus Co Ltd.

What unique competitive advantages
does Knotus Co Ltd hold over its rivals?

What risks and challenges
does Knotus Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Knotus Co Ltd.

Provide P/S
for Knotus Co Ltd.

Provide P/E
for Knotus Co Ltd.

Provide P/OCF
for Knotus Co Ltd.

Provide P/FCFE
for Knotus Co Ltd.

Provide P/B
for Knotus Co Ltd.

Provide EV/S
for Knotus Co Ltd.

Provide EV/GP
for Knotus Co Ltd.

Provide EV/EBITDA
for Knotus Co Ltd.

Provide EV/EBIT
for Knotus Co Ltd.

Provide EV/OCF
for Knotus Co Ltd.

Provide EV/FCFF
for Knotus Co Ltd.

Provide EV/IC
for Knotus Co Ltd.

Compare the intrinsic valuations
of Knotus Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Knotus Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Knotus Co Ltd compared to its peers.

Compare the P/E ratios
of Knotus Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Knotus Co Ltd with its peers.

Analyze the financial leverage
of Knotus Co Ltd compared to its main competitors.

Show all profitability ratios
for Knotus Co Ltd.

Provide ROE
for Knotus Co Ltd.

Provide ROA
for Knotus Co Ltd.

Provide ROIC
for Knotus Co Ltd.

Provide ROCE
for Knotus Co Ltd.

Provide Gross Margin
for Knotus Co Ltd.

Provide Operating Margin
for Knotus Co Ltd.

Provide Net Margin
for Knotus Co Ltd.

Provide FCF Margin
for Knotus Co Ltd.

Show all solvency ratios
for Knotus Co Ltd.

Provide D/E Ratio
for Knotus Co Ltd.

Provide D/A Ratio
for Knotus Co Ltd.

Provide Interest Coverage Ratio
for Knotus Co Ltd.

Provide Altman Z-Score Ratio
for Knotus Co Ltd.

Provide Quick Ratio
for Knotus Co Ltd.

Provide Current Ratio
for Knotus Co Ltd.

Provide Cash Ratio
for Knotus Co Ltd.

What is the historical Revenue growth
over the last 5 years for Knotus Co Ltd?

What is the historical Net Income growth
over the last 5 years for Knotus Co Ltd?

What is the current Free Cash Flow
of Knotus Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Knotus Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Knotus Co Ltd

Current Assets 79.4B
Cash & Short-Term Investments 70.4B
Receivables 6.6B
Other Current Assets 2.4B
Non-Current Assets 92.3B
Long-Term Investments 47.1B
PP&E 40.7B
Intangibles 1.8B
Other Non-Current Assets 2.7B
Current Liabilities 64.7B
Accounts Payable 1.6B
Accrued Liabilities 631.2m
Short-Term Debt 1.7B
Other Current Liabilities 60.8B
Non-Current Liabilities 5.4B
Long-Term Debt 2.5B
Other Non-Current Liabilities 2.9B
Efficiency

Earnings Waterfall
Knotus Co Ltd

Revenue
52.8B KRW
Cost of Revenue
-16.4B KRW
Gross Profit
36.4B KRW
Operating Expenses
-37.7B KRW
Operating Income
-1.3B KRW
Other Expenses
1.1B KRW
Net Income
-164m KRW

Free Cash Flow Analysis
Knotus Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

Knotus Co Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

45/100
Profitability
Score

Knotus Co Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Knotus Co Ltd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
54/100
Solvency
Score

Knotus Co Ltd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Knotus Co Ltd

There are no price targets for Knotus Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Knotus Co Ltd

1M 1M
-13%
6M 6M
+25%
1Y 1Y
-13%
3Y 3Y
+2%
5Y 5Y
-17%
10Y 10Y
-17%
Annual Price Range
3 295
52w Low
2 455
52w High
4 675
Price Metrics
Average Annual Return 7.67%
Standard Deviation of Annual Returns 32.86%
Max Drawdown -93%
Shares Statistics
Market Capitalization 257.4B KRW
Shares Outstanding 85 024 885
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Knotus Co Ltd

Country

Korea

Industry

Life Sciences Tools & Services

Market Cap

257.4B KRW

Dividend Yield

0%

Description

KNOTUS Co. Ltd. engages in the provision of clinical research services. The company is headquartered in Incheon, Incheon. The company went IPO on 2019-11-27. is a Korea-based company principally engaged in the nonclinical experiment business. Along with subsidiaries, the Company operates its business through three segments. The Nonclinical Contract Research Organization (CRO) Business segment conducts nonclinical experiments on new developed substances such as new drugs, and tests the efficacy and pharmacodynamics of the substances. This segment also provides services including new drug development related equipment, software and analysis of experimental results. The Animal Laboratory Construction Business segment is engaged in the construction and design of animal laboratories and the supply of reagent consumables. The Pet Business segment is engaged in the development of animal medicines and the sale of pet supplies.

Contact

INCHEON
Incheon
38, Academy-ro 79beon-gil, Yeonsu-gu
+82328338899
http://www.knotus.co.kr/

IPO

2019-11-27

Employees

-

Officers

Co-Chief Executive Officer
Mr. Do-Hyung Kim

See Also

Discover More
What is the Intrinsic Value of one Knotus Co Ltd stock?

The intrinsic value of one Knotus Co Ltd stock under the Base Case scenario is 2 067.63 KRW.

Is Knotus Co Ltd stock undervalued or overvalued?

Compared to the current market price of 3 295 KRW, Knotus Co Ltd is Overvalued by 37%.